Stemline Therapeutics Inc. (STML) Fell -5.12% or -0.75 To Price $13.9 On Monday


Stemline Therapeutics Inc. (STML) fell -5.12% or -0.75 to $13.9. It is near to 253358 shares traded, which is 118.79% compare to the average total volume 213289. The market cap of STML is $351.49 million. The year to date change is -6.39%. The 52 week price range is from $5.5 to $16.2. Price of STML have changed -6.09% during last week. It have changed -2.17% over last month, 24.68% over last 3 months, 55.03% over last 6 months and 10.98% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for STML is 14.10. It is 1.44% above current price. The 200-day Moving Averages for STML is 10.37. It is -25.40% below current price. The 52-week High is 16.2. It is 16.55% from the current price. The 52-week Low is 5.5. It is -60.43% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of STML is 7.5 on 2017-12-15. Short % to float is 7.61%. There are some statistics of STML. It is has market cap $351.49 million. The share outstanding is 25.29 million. The average volume is 213289. The percent of top 15 Institution holding is 59.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of STML is -84.95%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of STML is -71.95%.


Tags:

Share this post